Polymerase chain reaction-single strand conformational polymorphism analysis of rearranged during transfection proto-oncogene in Chinese familial hirschsprung's disease

World Journal of Gastroenterology

Volumn 11, Issue 2, 2005, Pages 275-279

  Guan, Tao ^a   Li, Ji Cheng ^a   Li, Min Ju ^a   Tou, Jin Fa ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hirschsprung's disease; PCR SSCP; Proto oncogene proteins RET; Transfection

Indexed keywords

GENOMIC DNA; GUANINE; LEUCINE; PROTEIN RET; THYMINE;

ARTICLE; CHINESE; DNA EXTRACTION; ELECTROPHORESIS; EXON; FAMILIAL DISEASE; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; GENE REARRANGEMENT; GENEALOGY; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; GENETIC TRANSFECTION; HETEROZYGOSITY; HETEROZYGOTE DETECTION; HIRSCHSPRUNG DISEASE; HUMAN; MALE; MUTATIONAL ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; PATHOGENESIS; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PROTO ONCOGENE; SINGLE STRAND CONFORMATION POLYMORPHISM; VENOUS BLOOD;

EID: 12344265693     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i2.275     Document Type: Article

References (46)

1. Nogueira A, Campos M, Soares-Oliveira M, Estevao-Costa J, Silva P, Carneiro F, Carvalho JL. Histochemical and immunohistochemical study of the intrinsic innervation in colonic dysganglionosis. Pediatr Surg Int 2001; 17: 144-151
2. Yoneda A, Wang Y, O'Briain DS, Puri P. Cell-adhesion molecules and fibroblast growth factor signalling in Hirschsprung's disease. Pediatr Surg Int 2001; 17: 299-303
3. Li JC, Mi KH, Zhou JL, Busch L, Kuhnel W. The development of colon innervation in trisomy 16 mice and Hirschsprungs disease. World J Gastroenterol 2001; 7: 16-21
4. Won KJ, Torihashi S, Mitsui-Saito M, Hori M, Sato K, Suzuki T, Ozaki H, Karaki H. Increased smooth muscle contractility of intestine in the genetic null of the endothelin ETB receptor: a rat model for long segment Hirschsprung's disease. Gut 2002; 50: 355-360
5. Amiel J, Lyonnet S. Hirschsprung disease, associated syndromes, and genetics: a review. J Med Genet 2001; 38: 729-739
6. Rice J, Doggett B, Sweetser DA, Yanagisawa H, Yanagisawa M, Kapur RP. Transgenic rescue of aganglionosis and piebaldism in lethal spotted mice. Dev Dyn 2000; 217: 120-132
7. Iwashita T, Kurokawa K, Qiao S, Murakami H, Asai N, Kawai K, Hashimoto M, Watanabe T, Ichihara M, Takahashi M. Functional analysis of RET with Hirschsprung mutations affecting its kinase domain. Gastroenterology 2001; 121: 24-33
8. Griseri P, Pesce B, Patrone G, Osinga J, Puppo F, Sancandi M, Hofstra R, Romeo G, Ravazzolo R, Devoto M, Ceccherini I. A rare haplotype of the RET proto-oncogene is a risk-modifying allele in hirschsprung disease. Am J Hum Genet 2002; 71: 969-974
9. Manie S, Santoro M, Fusco A, Billaud M. The RET receptor: function in development and dysfunction in congenital malformation. Trends Genet 2001; 17: 580-589
10. Japon MA, Urbano AG, Saez C, Segura DI, Cerro AL, Dieguez C, Alvarez CV. Glial-derived neurotropic factor and RET gene expression in normal human anterior pituitary cell types and in pituitary tumors. J Clin Endocrinol Metab 2002; 87: 1879-1884
11. Gershon MD. Lessons from genetically engineered animal models. II. Disorders of enteric neuronal development: insights from transgenic mice. Am J Physiol 1999; 277(2Pt 1): G262-267
12. Onochie CI, Korngut LM, Vanhorne JB, Myers SM, Michaud D, Mulligan LM. Characterisation of the human GFRalpha-3 locus and investigation of the gene in Hirschsprung disease. J Med Genet 2000; 37: 674-679
13. Inoue K, Shimotake T, Iwai N. Mutational analysis of RET/GDNF/NTN genes in children with total colonic aganglionosis with small bowel involvement. Am J Med Genet 2000; 93: 278-284
14. Gath R, Goessling A, Keller KM, Koletzko S, Coerdt W, Muntefering H, Wirth S, Hofstra RM, Mulligan L, Eng C, von-Deimling A. Analysis of the RET, GDNF, EDN3, and EDNRB genes in patients with intestinal neuronal dysplasia and Hirschsprung disease. Gut 2001; 48: 671-675
15. Julies MG, Moore SW, Kotze MJ, du Plessis L. Novel RET mutations in Hirschsprung's disease patients from the diverse South African population. Eur J Hun Genet 2001; 9: 419-423
16. Inoue K, Shimotake T, Tomiyama H, Iwai N. Mutational analysis of the RET and GDNF gene in children with hypoganglionosis. Eur J Pediatr Surg 2001; 11: 120-123
17. Shimotake T, Go S, Inoue K, Tomiyama H, Iwai N. A homozygous missense mutation in the tyrosine E kinase domain of the RET proto-oncogene in an infant with total intestinal aganglionosis. Am J Gastroenterol 2001; 96: 1286-1291
18. Hofstra RM, Wu Y, Stulp RP, Elfferich P, Osinga J, Maas SM, Siderius L, Brooks AS, vdEnde JJ, Heydendael VM, Severijnen RS, Bax KM, Meijers C, Buys CH. RET and GDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems. Hum Mutat 2000; 15: 418-429
19. Sancandi M, Ceccherini I, Costa M, Fava M, Chen B, Wu Y, Hofstra R, Laurie T, Griffths M, Burge D, Tam PK. Incidence of RET mutation in patients with Hirschsprung's disease. J Pediatr Surg 2000; 35: 139-142
20. Fitze G, Cramer J, Ziegler A, Schierz M, Schreiber M, Kuhlisch E, Roesner D, Schackert HK. Association between c135G/A genotype and RET proto-oncogene germline mutations and phenotype of Hirschsprung's disease. Lancet 2002; 359: 1200-1205
21. Pigny P, Bauters C, Wemeau JL, Houcke ML, Crepin M, Caron P, Giraud S, Calender A, Buisine MP, Kerckaert JP, Porchet N. A novel 9-base pair duplication in RET exon 8 in familial medullary thyroid carcinoma. J Clin Endocrinol Metab 1999; 84: 1700-1704
22. Borrego S, Ruiz A, Saez ME, Gimm O, Gao X, Lopez-Alonso M, Hernandez A, Wright FA, Antinolo G, Eng C. RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease. J Med Genet 2000; 37: 572-578
23. Martucciello G, Ceccherini I, Lerone M, Jasonni V. Pathogenesis of Hirschsprung's disease. J Pediatr Surg 2000; 35 1017-1025
24. Bolk S, Pelet A, Hofstra RM, Angrist M, Salomon R, Croaker D, Buys CH, Lyonnet S, Chakravarti A. A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus. Proc Natl Acad Sci USA 2000; 97: 268-273
25. Khan AR, Vujanic GM, Huddart S. The constipated child: how likely is Hirschsprung's disease? Pediatr Surg Int 2003; 19 439-442
26. Pepinski W, Soltyszewski I, Janica J, Skawronska M, Koc-Zorawska E. Comparison of five commercial kits for DNA extraction from human blood, saliva and muscle samples. Rocz Akad Med Bialymst 2002; 47: 270-275
27. Lesueur F, Corbex M, McKay JD, Lima J, Soares P, Griseri P, Burgess J, Ceccherini I, Landolfi S, Papotti M, Amorim A, Goldgar DE, Romeo G. Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma. J Med Genet 2002; 39: 260-265
28. Melillo RM, Santoro M, Ong SH, Billaud M, Fusco A, Hadari YR, Schlessinger J, Lax I. Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade. Mol Cell Biol 2001; 21: 4177-4187
29. Griseri P, Sancandi M, Patrone G, Bocciardi R, Hofstra R, Ravazzolo R, Devoto M, Romeo G, Ceccherini I. A single-nucleotide polymorphic variant of the RET proto-oncogene is underrepresented in sporadic Hirschsprung disease. Eur J Hum Genet 2000; 8: 721-724
30. Hansford JR, Mulligan LM. Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet 2000; 37: 817-827
31. Munnes M, Patrone G, Schmitz B, Romeo G, Doerfler W. A 5′-CG-3′-rich region in the promoter of the transcriptionally frequently silenced RET protooncogene lacks methylated cytidine residues. Oncogene 1998; 17: 2573-2583
32. Munnes M, Fanaei S, Schmitz B, Muiznieks I, Holschneider AM, Doerfler W. Familial form of hirschsprung disease: nucleotide sequence studies reveal point mutations in the RET proto-oncogene in two of six families but not in other candidate genes. Am J Med Genet 2000; 94: 19-27
33. Parisi MA, Kapur RP. Genetics of Hirschsprung disease. Curr Opin Pediatr 2000; 12: 610-617
34. Amiel J, Salomon R, Attie-Bitach T, Touraine R, Steffann J, Pelet A, Nihoul-Fekete C, Vekemans M, Munnich A, Lyonnet S. Molecular genetics of Hirschsprung disease: a model of multigenic neurocristopathy. J Soc Biol 2000; 194: 125-128
35. Matera I, De Miguel-Rodriguez M, Fernandez-Santos JM, Santamaria G, Puliti A, Ravazzolo R, Romeo G, Galera-Davidson H, Ceccherini I. cDNA sequence and genomic structure of the rat RET proto-oncogene. DNA Seq 2000; 11: 405-417
36. Sakai T, Nirasawa Y, Itoh Y, Wakizaka A. Japanese patients with sporadic Hirschsprung: mutation analysis of the receptor tyrosine kinase proto-oncogene, endothelin-B receptor, endothelin-3, glial cell line-derived neurotrophic factor and neurturin genes: a comparison with similar studies. Eur J Pediatr 2000; 159: 160-167
37. De Vita G, Melillo RM, Carlomagno F, Visconti R, Castellone MD, Bellacosa A, Billaud M, Fusco A, Tsichlis PN, Santoro M. Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival. Cancer Res 2000; 60: 3727-3731
38. Fugazzola L, Cerutti N, Mannavola D, Ghilardi G, Alberti L, Romoli R, Beck-Peccoz P. Multigenerational familial medullary thyroid cancer (FMTC): evidence for FMTC phenocopies and association with papillary thyroid cancer. Clin Endocrinol 2002; 56: 53-63
39. Wohllk N, Becker P, Youlton R, Cote GJ, Gagel RF. Germline mutations of the ret proto-oncogene in Chilean patients with hereditary and sporadic medullary thyroid carcinoma. Rev Med Chil 2001; 129: 713-718
40. Lore F, Talidis F, Di Cairano G, Renieri A. Multiple endocrine neoplasia type 2 syndromes may be associated with renal malformations. J Intern Med 2001; 250: 37-42
41. Takano T, Miyauchi A, Yoshida H, Hasegawa Y, Kuma K, Amino N. Large-scale analysis of mutations in RET exon 16 in sporadic medullary thyroid carcinomas in Japan. Jpn J Cancer Res 2001; 92 645-648
42. Chiefari E, Chiarella R, Crocetti U, Tardio B, Arturi F, Russo D, Trischitta V, Filetti S, Zingrillo M. A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC. Horm Metab Res 2001; 33: 52-56
43. Garcia-Barcelo M, Sham MH, Lee WS, Lui VC, Chen BL, Wong KK, Wong JS, Tam PK. Highly recurrent RET mutations and novel mutations in genes of the receptor tyrosine kinase and endothelin receptor B pathways in Chinese patients with sporadic Hirschsprung disease. Clin Chem 2004; 50: 93-100
44. Sakai T, Wakizaka A, Nirasawa Y. Congenital central hypoventilation syndrome associated with Hirschsprung's disease: mutation analysis of the RET and endothelin-signaling pathways. Eur J Pediatr Surg 2001; 11: 335-337
45. Pasini B, Rossi R, Ambrosio MR, Zatelli MC, Gullo M, Gobbo M, Collini P, Aiello A, Pansini G, Trasforini G, degli Uberti EC. RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease. Surgery 2002; 131: 373-381
46. Mograbi B, Bocciardi R, Bourget I, Juhel T, Farahi-Far D, Romeo G, Ceccherini I, Rossi B. The sensitivity of activated Cys Ret mutants to glial cell line-derived neurotrophic factor is mandatory to rescue neuroectodermic cells from apoptosis. Mol Cell Biol 2001; 21: 6719-6730